These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1703026)
1. Role of central tachykinin peptides in cardiovascular regulation in rats. Takano Y; Nagashima A; Hagio T; Tateishi K; Kamiya H Brain Res; 1990 Oct; 528(2):231-7. PubMed ID: 1703026 [TBL] [Abstract][Full Text] [Related]
2. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig. Roccon A; Marchionni D; Nisato D Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331 [TBL] [Abstract][Full Text] [Related]
3. The central pressor actions of a novel tachykinin peptide, gamma-preprotachykinin-(72-92)-peptide amide. Hagio T; Takano Y; Nagashima A; Nakayama Y; Tateishi K; Kamiya H Eur J Pharmacol; 1991 Jan; 192(1):173-6. PubMed ID: 1710187 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P; Regoli D; Couture R Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304 [TBL] [Abstract][Full Text] [Related]
5. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats. Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176 [TBL] [Abstract][Full Text] [Related]
6. Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats. Saigo A; Takano Y; Matsumoto T; Tran M; Nakayama Y; Saito R; Yamada K; Kamiya H Neurosci Lett; 1993 Sep; 159(1-2):187-90. PubMed ID: 7505413 [TBL] [Abstract][Full Text] [Related]
7. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. Picard P; Chrétien L; Couture R Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280 [TBL] [Abstract][Full Text] [Related]
8. Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus. Nakayama Y; Takano Y; Saito R; Kamiya H Brain Res; 1992 Nov; 595(2):339-42. PubMed ID: 1281741 [TBL] [Abstract][Full Text] [Related]
9. Interrelationship between central bradykinin and vasopressin in conscious rats. Brooks DP; Share L; Crofton JT; Nasjletti A Brain Res; 1986 Apr; 371(1):42-8. PubMed ID: 3754782 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Savci V; Cavun S; Goktalay G; Ulus IH Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025 [TBL] [Abstract][Full Text] [Related]
11. Effects of intracerebroventricular injected choline on cardiovascular functions and sympathoadrenal activity. Arslan BY; Ulus IH; Savci V; Kiran BK J Cardiovasc Pharmacol; 1991 May; 17(5):814-21. PubMed ID: 1713998 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses. Unger T; Becker H; Petty M; Demmert G; Schneider B; Ganten D; Lang RE Circ Res; 1985 Apr; 56(4):563-75. PubMed ID: 2579749 [TBL] [Abstract][Full Text] [Related]
13. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B. Culman J; Wiegand B; Spitznagel H; Klee S; Unger T Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533 [TBL] [Abstract][Full Text] [Related]
14. Vasopressin: mechanism of central cardiovascular action in conscious rats. Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805 [TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular choline reverses hypotension induced by acute chemical sympathectomy. Gürün MS; Savci V; Ulus IH J Auton Pharmacol; 1997 Jun; 17(3):155-63. PubMed ID: 9278775 [TBL] [Abstract][Full Text] [Related]
16. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats. Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779 [TBL] [Abstract][Full Text] [Related]
17. Possible mechanisms underlying the hypertensive response to clonidine in freely moving, normotensive rats. Kawasaki H; Yamamoto R; Takasaki K Jpn J Pharmacol; 1986 Nov; 42(3):405-17. PubMed ID: 3820860 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin. Cornish JL; van den Buuse M Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292 [TBL] [Abstract][Full Text] [Related]
19. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R Br J Pharmacol; 1992 Nov; 107(3):750-5. PubMed ID: 1335337 [TBL] [Abstract][Full Text] [Related]
20. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. Anderson IK; Martin GR; Ramage AG Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]